Skip to main content
Erschienen in: American Journal of Clinical Dermatology 1/2013

01.02.2013 | Short Communication

Depigmentation Patterns of Nonsegmental Vitiligo

A Prospective Study of Macromorphologic Changes in Lesions

verfasst von: Giovanni Menchini, Claudio Comacchi, Pietro Cappugi, Daniele Torchia

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Efforts have been recently made to investigate simple, objective, accurate, and reproducible methods of clinical/noninvasive assessment of nonsegmental vitiligo. However, studies have mostly considered quantitative or semiquantitative parameters, almost neglecting the purely qualitative appearance of vitiligo lesions at a given moment and over time.

Objective

The objective of this study was to investigate the dynamics of macromorphologic alterations taking place within vitiligo patches.

Study Design

This was a prospective study of a vitiligo cohort.

Patient Population

Consecutive patients affected by nonsegmental vitiligo.

Methods

Enrolled patients affected by nonsegmental vitiligo underwent a dermatology visit once monthly for 12 months. Vitiligo lesions were photographed at each visit under both room light and Wood’s light, and analyzed via a morphometric, digitalized software capable of detecting quantitative changes of white areas. Pictures depicting changing patches were evaluated in order to assess clinical morphology.

Results

Ninety patients were included for the final analysis and 360 lesions were evaluated, 102 of which (28.9 %) showed changes of white areas. Subjective evaluation highlighted two distinct depigmentation patterns, which were present either alone or in combination: (1) a sharply defined band of intermediate color between the depigmented center and the surrounding normal skin, which was defined as ‘marginal hypopigmentation;’ and (2) pinpoint hypopigmented/depigmented macules centered by a follicle, which we named ‘perifollicular depigmentation.’ On the other hand, only one repigmentation pattern was detected, the already known ‘perifollicular repigmentation.’

Conclusion

The depigmentation process in vitiligo seems to follow only two specific patterns. This preliminary study represents, in our opinion, a valuable background for future research aiming to investigate the dynamics of vitiligo pathogenesis or assess depigmentation/repigmentation patterns for monitoring treatment response.
Literatur
1.
Zurück zum Zitat Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65:473–91.PubMedCrossRef Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65:473–91.PubMedCrossRef
2.
Zurück zum Zitat Taïeb A, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.PubMedCrossRef Taïeb A, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.PubMedCrossRef
3.
Zurück zum Zitat Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149–56.PubMedCrossRef Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149–56.PubMedCrossRef
4.
Zurück zum Zitat Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview. Part II: treatment options and approach to treatment. J Am Acad Dermatol. 2011;65:493–514.PubMedCrossRef Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview. Part II: treatment options and approach to treatment. J Am Acad Dermatol. 2011;65:493–514.PubMedCrossRef
5.
Zurück zum Zitat Hamzavi I, Jain H, McLean D, et al. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140:677–83.PubMedCrossRef Hamzavi I, Jain H, McLean D, et al. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140:677–83.PubMedCrossRef
6.
Zurück zum Zitat Aydin F, Senturk N, Sahin B, et al. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol. 2007;17:30–2.PubMed Aydin F, Senturk N, Sahin B, et al. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol. 2007;17:30–2.PubMed
7.
Zurück zum Zitat Marrakchi S, Bouassida S, Meziou TJ, et al. An objective method for the assessment of vitiligo treatment. Pigment Cell Melanoma Res. 2008;21:106–7.PubMedCrossRef Marrakchi S, Bouassida S, Meziou TJ, et al. An objective method for the assessment of vitiligo treatment. Pigment Cell Melanoma Res. 2008;21:106–7.PubMedCrossRef
8.
Zurück zum Zitat Lai LG, Xu AE. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus. Skin Res Technol. 2011;17:404–10.PubMedCrossRef Lai LG, Xu AE. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus. Skin Res Technol. 2011;17:404–10.PubMedCrossRef
9.
Zurück zum Zitat Sharquie KE. Stages of depigmentation in vitiligo. Iraqi Med J. 1988;36:47–50. Sharquie KE. Stages of depigmentation in vitiligo. Iraqi Med J. 1988;36:47–50.
10.
Zurück zum Zitat Anbar TS, El-Sawy AE, Attia SK, Moftah NH, El-Tonsy MH. Patterns of repigmentation in two cases of hypopigmented type of vitiligo. Photodermatol Photoimmunol Photomed. 2009;25:156–8.PubMedCrossRef Anbar TS, El-Sawy AE, Attia SK, Moftah NH, El-Tonsy MH. Patterns of repigmentation in two cases of hypopigmented type of vitiligo. Photodermatol Photoimmunol Photomed. 2009;25:156–8.PubMedCrossRef
11.
Zurück zum Zitat Parsad D, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004;50:63–7.PubMedCrossRef Parsad D, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004;50:63–7.PubMedCrossRef
12.
Zurück zum Zitat Kim DY, Cho SB, Park YK. Various patterns of repigmentation after narrowband UVB monotherapy in patients with vitiligo. J Dermatol. 2005;32:771–2.PubMed Kim DY, Cho SB, Park YK. Various patterns of repigmentation after narrowband UVB monotherapy in patients with vitiligo. J Dermatol. 2005;32:771–2.PubMed
13.
Zurück zum Zitat Yang YS, Cho HR, Ryou JH, Lee MH. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients. Int J Dermatol. 2010;49:317–23.PubMedCrossRef Yang YS, Cho HR, Ryou JH, Lee MH. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients. Int J Dermatol. 2010;49:317–23.PubMedCrossRef
14.
Zurück zum Zitat Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol. 2000;42:589–96.PubMed Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol. 2000;42:589–96.PubMed
15.
Zurück zum Zitat Tel-D Anbar, Abdel-Raouf H, Awad SS, Ragaie MH. Perifollicular inflammatory infiltrate in vitiligo. Int J Dermatol. 2011;50:234–7.CrossRef Tel-D Anbar, Abdel-Raouf H, Awad SS, Ragaie MH. Perifollicular inflammatory infiltrate in vitiligo. Int J Dermatol. 2011;50:234–7.CrossRef
16.
Zurück zum Zitat Sharquie KE, Mehenna SH, Naji AA, Al-Azzawi H. Inflammatory changes in vitiligo: stage I and II depigmentation. Am J Dermatopathol. 2004;26:108–12.PubMedCrossRef Sharquie KE, Mehenna SH, Naji AA, Al-Azzawi H. Inflammatory changes in vitiligo: stage I and II depigmentation. Am J Dermatopathol. 2004;26:108–12.PubMedCrossRef
Metadaten
Titel
Depigmentation Patterns of Nonsegmental Vitiligo
A Prospective Study of Macromorphologic Changes in Lesions
verfasst von
Giovanni Menchini
Claudio Comacchi
Pietro Cappugi
Daniele Torchia
Publikationsdatum
01.02.2013
Verlag
Springer International Publishing AG
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 1/2013
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-012-0001-9

Weitere Artikel der Ausgabe 1/2013

American Journal of Clinical Dermatology 1/2013 Zur Ausgabe

Evidence-Based Review Article

Combination Therapy in Psoriasis

Adis Drug Clinical Q&A

Vemurafenib

Adis Drug Clinical Q&A

Vismodegib

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.